Urology
Volume 66, Issue 5 , Pages 1038-1042, November 2005

Estimation of treatment benefits when PSA screening for prostate cancer is discontinued at different ages

  • Kevin S. Ross

      Affiliations

    • Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland
    • ,
  • Harry A. Guess

      Affiliations

    • Department of Epidemiology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina
    • ,
  • H. Ballentine Carter

      Affiliations

    • Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland
    • James Buchanan Brady Urological Institute, Johns Hopkins Hospital, Baltimore, Maryland
    • Corresponding Author InformationReprint requests: H. Ballentine Carter, M.D., Department of Urology, 403 Marburg, Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, MD 21287-2101.

Received 28 August 2004; accepted 12 May 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0090-4295(05)00754-5

doi:10.1016/j.urology.2005.05.030

Urology
Volume 66, Issue 5 , Pages 1038-1042, November 2005

Article Tools

* Image Usage & Resolution